SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001264124-06-000173
Filing Date
2006-04-11
Accepted
2006-04-11 18:08:25
Documents
2
Period of Report
2006-03-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 3452
2 EDGAR SUPPORTING DOCUMENT altmanpoa.txt EX-24 2119
  Complete submission text file 0001264124-06-000173.txt   7370
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Issuer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 5775 MOREHOUSE DR SAN DIEGO CA 92121 8586514394
ALTMAN STEVEN R (Reporting) CIK: 0001191307 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19700 | Film No.: 06754459